Communications
News & Press Release
-
CNR Research Applies for Phase 2 Pre-IND of Multi-Race Clinical Trials for Dementia/Obesity Treatment.2023.10.04
-
CNR Research "U.S. FDA Pre-IND Application for Dementia and Obesity Treatment Substances".2023.10.04
-
CNR Research Signs FDA Pre-IND Contract For Neurobiogen Dementia/Obesity Treatment.2023.10.04
-
CNR Research Signs U.S. FDA Pre-IND With NeuroBiogen.2023.10.04
-
CNR Research, Neurobiogen U.S. FDA Pre-IND Contract.2023.10.04